Bordet Scientific Publications

Bordet Scientific Publications

  • Collecting behavioural data across countries during pandemics: Development of the COVID-19 Risk Assessment Tool.

  • Auteurs Peters GJ, Kwasnicka D, Ten Hoor GA, Crutzen R, Varol T, Warner LM, Algargoosh M, Ali EE, Anwar M, Asih SR, Baltas ZF, Berry E, Beyene K, Campbell KA, Carneiro BM, Castillo-Eito L, Chan AHY, Chan SS, Cipolletta S, DeSmet A, Dewi TK, Dima AL, Encantado J, Epton T, Figueiredo J, Fracaroli GD, Gauchet A, Gebretekle GB, Gérain P, Godinho CA, Graham-Wisener L, Green JA, Groarke JM, Gültzow T, Guven EB, Hermans RCJ, Hermsen S, Inauen J, Kassianos AP, Kazantseva TV, Keyaerts E, König LM, Lange D, Lauwerier E, Lie Y, Liem A, Luszczynska A, Marques MM, Moore HC, Noone C, Nurmi J, Nurwanti R, Ozbay ES, Palacz-Poborczyk I, Pedruzzi RA, Poppe L, Porter LM, Powell D, Rinaldi BSN, Ruffault A, Schmitz C, Scholz U, Schweitzer AM, Ok YS, Shree M, Silva CC, Sokang YA, Tam AW, Tang MY, Tomaino SCM, van Beurden SB, Verweij S, Vluggen S, Watkins RE, Zörgő S, Roozen S
  • Auteurs (entité) DESMET ANTOINE
  • Revue Behav Res Methods
  • Date de publication 2025-07
Collecting behavioural data across countries during pandemics: Development of the COVID-19 Risk Assessment Tool.
  • Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE Trial.

  • Auteurs Peccatori FA, Niman SM, Partridge AH, Ruggeri M, Colleoni M, Saura C, Shimizu C, Satersdal AB, Kroep JR, Gelmon K, Amant F, Mailliez A, Moore HCF, Ruiz-Borrego M, Walshe JM, Borges VF, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Saunders C, Bjelic-Radisic V, Susnjar S, Cardoso F, Klar NJ, Ferreiro T, El-Abed S, Piccart M, Korde LA, Goldhirsch A, Gelber RD, Pagani O, Azim HA
  • Auteurs (entité) GOMBOS ANDREA
  • Revue J Clin Oncol
  • Date de publication 2025-07
Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE Trial.
  • Human papillomavirus infection is a favorable prognostic factor for patients with stage I-IVA esophageal squamous cell carcinoma but not adenocarcinoma.

  • Auteurs Reynders C, Bruyere D, Roncarati P, Geuzaine R, Koopmansch B, Gofflot S, Monnien F, Craciun L, Piazzon N, Hendrick E, Poulain F, Lerho T, Miceli S, Pilard C, Ancion M, Luyckx M, Renard M, Lambert F, Gheit T, Molimard C, Bibeau F, Larsimont D, Fasquelle F, de Leval L, Delvenne P, Kervarrec T, Hubert P, Peulen O, Herfs M
  • Auteurs (entité) LARSIMONT DENIS
  • Revue Mod Pathol
  • Date de publication 2025-07
Human papillomavirus infection is a favorable prognostic factor for patients with stage I-IVA esophageal squamous cell carcinoma but not adenocarcinoma.
  • STRONG II trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma - a single-arm multicentre phase II study.

  • Auteurs van Loosbroek SY, Milder MTW, de Ruysscher D, Vaes RDW, den Toom W, Willemssen F, Eskens F, Homs MYV, Groot Koerkamp B, van Driel LMJW, Seppenwoolde Y, van Werkhoven E, Intven M, Haj Mohammad N, de Bruijne J, Versteijne E, Bruynzeel AM, Brandts F, Erdmann JI, Westdorp H, Braam PM, Tjwa ETTL, Bouchart C, Demols A, Gulyban A, Buijsen J, de Vos-Geelen J, Dewulf M, Joye I, Vandamme T, Vonghia L, de Groot DJ, Dieters M, Ubbels FJF, Hoogwater FJH, Heijmen B, Méndez Romero A
  • Auteurs (entité) GULYBAN AKOS
  • Revue BMJ Open
  • Date de publication 2025-07
STRONG II trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma - a single-arm multicentre phase II study.
Erasme hospital

Erasme Hospital

View all of Erasme's scientific publications

Huderf hospital

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital

Bordet hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications